CHARLIE MYERS: Open Payments
NPI 1164190385 · WALNUT CREEK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,027 in 58 payments from 16 companies in 2025. Trend: 2023 $415 · 2024 $1,592 · 2025 $2,027
Food & beverage: $2,027
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $812 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $184 |
| Novartis Pharmaceuticals Corporation | 11 | $181 |
| CVRx, Inc. | 1 | $174 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $126 |
| Amgen Inc. | 6 | $100 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $76 |
| SCPHARMACEUTICALS INC. | 3 | $70 |
| Edwards Lifesciences Corporation | 3 | $60 |
| Esperion Therapeutics, Inc. | 3 | $53 |
Products named: Rapiblyk, Kerendia, LEQVIO, Barostim Neo System, JARDIANCE, REPATHA, LifeVest, FUROSCIX.
Industry payments across CA — which companies pay providers there.
